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Expert Commentary 807 Antiplatelet agents used for early intervention in acute coronary syndrome:
Myocardial salvage versus bleeding complications
Sary F. Aranki, MD, and Simon C. Body, MBChB, MPH, Boston, Mass
General Thoracic
Surgery (GTS)
811 In situ tissue engineering for tracheal reconstruction using a luminar
remodeling type of artificial trachea
Tatsuo Nakamura, MD, Toshihiko Sato, Masato Araki, MD, Satoshi Ichihara, MD,
Akira Nakada, MD, Makoto Yoshitani, MD, Shin-ichi Itoi, MD, Masaru Yamashita, MD,
Shin-ichi Kanemaru, MD, Kouichi Omori, MD, Yoshio Hori, MD, Katsuaki Endo, MD,
Yuji Inada, MD, and Katsumi Hayakawa, MD, Kyoto and Fukushima, Japan
Artificial tracheas made from polypropylene mesh and atelocollagen layers were evaluated after
their collagen had been soaked in various media. Bone marrow aspirate and mesenchymal stem
cells had an advantage in performance of tissue regeneration in comparison with peripheral
blood.
820 Pulmonary aspergilloma: Analysis of prognosis in relation to symptoms
and treatment
Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD, Dae Joon Kim, MD,
Joon Chang, MD, PhD, Se Kyu Kim, MD, PhD, and Kyung Young Chung, MD,
Seoul, South Korea
Early morbidity and mortality rates of surgical treatment for pulmonary aspergilloma are acceptable;
surgical treatment is helpful not only to reduce symptoms but also to prolong the survival of patients
with pulmonary aspergilloma. Surgical resection should be considered for all patients with
pulmonary aspergilloma who have acceptable pulmonary reserve.
826 Asymptomatic congenital cystic adenomatoid malformation of the lung:
Is it time to operate?
Andrea Conforti, MD, Ivan Aloi, MD, Alessandro Trucchi, MD, Francesco Morini, MD,
Antonella Nahom, MD, Alessandro Inserra, MD, and Pietro Bagolan, MD, Rome, Italy
The treatment of congenital adenomatoid malformation of the lung remains controversial. Surgical
removal of asymptomatic lesions is safe, presenting a lower complication rate in comparison with
removal of symptomatic lesions, and it is not influenced by young age at the time of the
operation.
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S831 Impact of tumor length on long-term survival of pT1 esophageal
adenocarcinoma
William D. Bolton, MD, Wayne L. Hofstetter, MD, Ashleigh M. Francis, BS, Arlene M. Correa, MD,
Jaffer A. Ajani, MD, Manoop S. Bhutani, MD, Jeremy Erasmus, MD, Ritsuko Komaki, MD,
Dipen M. Maru, MD, Reza J. Mehran, MD, David C. Rice, MD, Jack A. Roth, MD,
Ara A. Vaporciyan, MD, Garrett L. Walsh, MD, and Stephen G. Swisher, MD, Houston, Tex
Tumor length (.3 cm) is a predictor of survival in pT1 esophageal adenocarcinoma. The
combination of tumor length (.3 cm) and submucosal involvement identifies a high-risk group of
patients with pT1 esophageal adenocarcinoma who are at increased risk for lymph node metastasis
and poor long-term survival.
837 Intraoperative ultrasonographic localization of pulmonary ground-glass
opacities
Ryoichi Kondo, MD, PhD, Kazuo Yoshida, MD, PhD, Kazutoshi Hamanaka, MD,
Masahiro Hashizume, MD, Toshiki Ushiyama, MD, Akira Hyogotani, MD, Makoto Kurai, MD,
Satoshi Kawakami, MD, Mana Fukushima, MD, and Jun Amano, MD, PhD, Matsumoto, Japan
Intraoperative ultrasonography can both safely and effectively localize pulmonary GGOs in
a completely deflated lung. This procedure is also useful for the evaluation of surgical margins in
a resected lung. Hence, ultrasonography may assist surgeons to perform minimally invasive lung
resections with clear surgical margins during the treatment of solitary lung GGO.
843 Venous thromboembolism in patients receiving multimodality therapy
for thoracic malignancies
Apurva Patel, MD, Masaki Anraku, MD, Gail E. Darling, MD, Frances A. Shepherd, MD,
Andrew F. Pierre, MD, Thomas K. Waddell, MD, Shaf Keshavjee, MD, and
Marc de Perrot, MD, MSc, Toronto, Ontario, Canada
This retrospective study demonstrates that the rate of venous thromboembolism in patients
undergoing induction therapy for non–small cell lung cancer or malignant pleural mesothelioma is
high, but a preoperative diagnosis of venous thromboembolism does not affect the early or late
outcome after surgery.
849 Is there a subset of patients with preoperatively diagnosed N2 non–small cell
lung cancer who might benefit from surgical resection?
Giovanni B. Ratto, MD, Roberta Costa, MD, Paola Maineri, MD, Antonella Alloisio, MD,
Paolo Bruzzi, MD, and Beatrice Dozin, PhD, Genoa and Alessandria, Italy
This study, which included 277 patients who underwent resection of preoperatively diagnosed N2
non–small cell lung cancer, was aimed at identifying significant prognostic factors delineating subsets
of patients who might benefit from resection. Risk scores for both preoperative and postoperative
selection of patients with better prognoses are provided.
Acquired Cardiovascular
Disease (ACD)
859 Long-term results of aortic valve–sparing operations in patients with Marfan
syndrome
Tirone E. David, MD, Sue Armstrong, BSc, Manjula Maganti, BSc, Jack Colman, MD, and
Timothy J. Bradley, MBChB, Toronto, Ontario, Canada
A prospective evaluation of 103 patients with Marfan syndrome who underwent aortic valve–sparing
operations during the past 2 decades revealed a survival of 87.2% and freedom from greater than mild
aortic insufficiency of 79.2% at 15 years. Complications of aortic dissections were the leading cause
of death.
(continued on page 16A)
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S865 Endovascular stent graft placement in patients with type B aortic dissection:
A meta-analysis in China
Jiang Xiong, PhD, MD, Bo Jiang, PhD, Wei Guo, MD, Shen-Ming Wang, PhD, MD, FACS, and
Xin-Yuan Tong, BM, Beijing and Guangzhou, China; and Seattle, Wash
This article is the first multicenter analysis of endovascular stent graft placement in type B aortic
dissection in China. Thirty-nine studies, involving a total of 1304 patients from January 2001 to
December 2007, were included. The clinical success, complications, and outcomes of these studies
were summarized and analyzed.
873 Obesity is associated with increased morbidity after coronary artery bypass
graft surgery in patients with renal insufficiency
Daniel A. Tolpin, MD, Charles D. Collard, MD, Vei-Vei Lee, MS, MacArthur A. Elayda, MD, PhD,
and Wei Pan, MD, Houston, Tex
Obesity is associated with increased cardiovascular morbidity and prolonged hospital stay in patients
with renal insufficiency undergoing primary coronary artery bypass graft surgery.
880 Predictive factors for endoleaks after thoracic aortic aneurysm endograft repair
Gabriele Piffaretti, MD, Giovanni Mariscalco, MD, PhD, Chiara Lomazzi, MD,
Nicola Rivolta, MD, Francesca Riva, MD, Matteo Tozzi, MD, Gianpaolo Carrafiello, MD,
Alessandro Bacuzzi, MD, Monica Mangini, MD, Maciej Banach, MD, PhD, and
Patrizio Castelli, MD, FACS, Varese, Italy, and Lodz, Poland
To date, the incidence and the determinants of endoleaks after thoracic endografting have not been
sufficiently investigated.We prospectively enrolled 61 patients affected by thoracic aortic aneurysms,
treated with thoracic stent graft. The diameter of the aneurysmal aorta and the position of the landing
zone were independent predictors of endoleak occurrence.
886 Results of mitral valve annuloplasty with a standard-sized posterior band:
Is measuring important?
Morgan L. Brown, MD, Hartzell V. Schaff, MD, Zhuo Li, MS, Rakesh M. Suri, MD,
Richard C. Daly, MD, and Thomas A. Orszulak, MD, Rochester, Minn
We studied 511 patients undergoing isolated mitral valve repair with standard-sized bands for
degenerative valve disease. Operative mortality was 0.8%, with excellent long-term results, good
durability, and neither excess gradients in larger patients nor excess regurgitation in smaller patients.
Measured annuloplasty is unnecessary for most adults undergoing mitral valve repair.
892 Is total arch replacement combined with stented elephant trunk implantation
justified for patients with chronic Stanford type A aortic dissection?
Li-Zhong Sun, MD, Rui-Dong Qi, MD, Qian Chang, MD, Jun-Ming Zhu, MD, Yong-Min Liu, MD,
Chun-Tao Yu, MD, Bin Lv, MD, Jun Zheng, MD, Liang-Xin Tian, MD, and Jin-Guo Lu, MD,
Beijing and Tianjin, China
Surgical management of chronic type A dissection using total arch replacement combined with
stented elephant trunk implantation is controversial. Our surgical results indicated that this technique
could be done for repair of chronic type A dissection: a low prevalence of morbidity andmortality was
obtained.
(continued on page 18A)
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S897 A comparison before and after aprotinin was suspended in cardiac
surgery: Different results in the real world from a single cardiac center
in China
Xianqiang Wang, MD, Zhe Zheng, MD, Hushan Ao, MD, Shiju Zhang, MD, Yang Wang, MD,
Hao Zhang, MD, Lihuan Li, MD, and Shengshou Hu, MD, Beijing, China
We compared the outcomes of two groups of patients who underwent cardiac surgery just before and
after aprotinin was suspended in China. Use of aprotinin could reduce blood loss and transfusion
requirement significantly and showed a protective effect on the lungs, but it did not increase the
mortality or major complications.
904 An Australian risk prediction model for 30-day mortality after isolated
coronary artery bypass: The AusSCORE
Christopher Reid, PhD, Baki Billah, PhD, Diem Dinh, PhD, Julian Smith, MBBS,
Peter Skillington, MBBS, Michael Yii, MBBS, Seven Seevanayagam, MBBS,
Morteza Mohajeri, MBBS, and Gil Shardey, MBBS, Melbourne and Victoria, Australia
We have developed a preoperative 30-day mortality risk prediction model for isolated CABG for the
Australian cohort.
Congenital Heart
Disease (CHD)
911 Long-term results of right ventricular outflow tract reconstruction in neonatal
cardiac surgery: Options and outcomes
Aditya K. Kaza, MD, Hong-Gook Lim, MD, Daniel J. Dibardino, MD, Victor Bautista-Hernandez, MD,
JoshuaRobinson,MD,CatherineAllan,MD,PeterLaussen,MBBS,FrancisFynn-Thompson,MD,Emile
Bacha, MD, Pedro J. del Nido, MD, John E. Mayer, Jr, MD, and Frank A. Pigula, MD, Boston, Mass
Neonatal reconstruction of the right ventricular outflow tract is required for the repair of tetralogy of
Fallot and truncus arteriosus. Although a variety of techniques have been developed to establish right
ventricle–pulmonary artery continuity in these patients, the durability of these procedures remains
a concern. We examined the durability of right ventricular outflow tract reconstructions in 278
neonates undergoing repair of tetralogy of Fallot and truncus arteriosus.
917 A new diagnostic algorithm for assessment of patients with single ventricle
before a Fontan operation
Ashwin Prakash, MD, Muhammad A. Khan, MD, Rose Hardy, BA, Alejandro J. Torres, MD,
Jonathan M. Chen, MD, and Welton M. Gersony, MD, New York, NY
A noninvasive diagnostic algorithm when applied retrospectively to 151 consecutive children before
a Fontan operation was effective in screening 9 subjects who were deemed inoperable. In addition,
omitting preoperative hemodynamic assessment did not impair prediction of an adverse postoperative
outcome.
924 Two-year neurodevelopmental outcomes of infants undergoing neonatal cardiac
surgery for interrupted aortic arch: A descriptive analysis
Chloe A. Joynt, MD, Charlene M. T. Robertson, MD, Po-Yin Cheung, MD, PhD,
Alberto Nettel-Aguirre, PhD, Ari R. Joffe, MD, Reg S. Sauve, MD, Wayne S. G. Biggs, BA,
Norma J. Leonard, MD, David B. Ross, MD, Ivan M. Rebeyka, MD, and the Western Canadian
Complex Pediatric Therapies Follow-up Group, Edmonton and Calgary, Alberta, Canada
Neurodevelopmental indices of children who undergo neonatal cardiac surgery for an interrupted
aortic arch are below normative values; those of children with chromosomal abnormalities are even
lower. For children without a chromosomal abnormality, deep hypothermic cardiac arrest time and
low Apgar score are predictive of mental delay.
(continued on page 20A)
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S933 Minimally invasive operation for congenital heart disease: A sex-differentiated
approach
VladimiroL.Vida,MD,PhD,MassimoA.Padalino,MD,PhD,GiovannaBoccuzzo,MPH,AltinA.Veshti,
MD, Simone Speggiorin, MD, Gianclaudio Falasco, MD, MPH, and Giovanni Stellin, MD, Padua, Italy
Minimally invasive sex-differentiated surgical approaches for surgical repair of simple congenital
heart diseases, including right anterior minithoracotomy in female subjects and midline
ministernotomy in male subjects is a safe procedure, providing both excellent functional and cosmetic
results. Anterolateral minithoracotomy is a valid and highly appreciated procedure in female patients.
937 Device management of arrhythmias after Fontan conversion
Sabrina Tsao, MD, Barbara J. Deal, MD, Carl L. Backer, MD, Kendra Ward, MD,
Wayne H. Franklin, MD, and Constantine Mavroudis, MD, Chicago, Ill, and Cleveland, Ohio
The evolution of pacemaker devices and leads is reviewed in 120 consecutive patients having Fontan
conversion with arrhythmia surgery. We currently recommend epicardial bipolar leads with DDDRT
pacemakers.
941 Pre-Fontan cardiac magnetic resonance predicts post-Fontan length of stay and
avoids ionizing radiation
Matthew A. Harris, MD, Michael T. Cosulich, BSE, Matthew J. Gillespie, MD,
Kevin K. Whitehead, MD, PhD, Timothy I. Liu, BA, Paul M. Weinberg, MD, and
Mark A. Fogel, MD, Philadelphia, Pa
Quantitative cardiac magnetic resonance (CMR) measurements of branch pulmonary artery size and
flow in pre-Fontan patients predict length of stay after the Fontan operation. CMR angiography can
thoroughly assess the cavopulmonary connection and branch pulmonary arteries without the use of
ionizing radiation.
Perioperative
Management (PM)
948 Prolonged mechanical ventilation after cardiac surgery: Outcome and
predictors
Jean-Louis Trouillet, MD, Alain Combes, MD, PhD, Elisabeth Vaissier, MD,
Charles-Edouard Luyt, MD, Alexandre Ouattara, MD, Alain Pavie, MD, PhD, and
Jean Chastre, MD, PhD, Paris, France
This study used multivariable regression analysis to identify independent predictors of successful
ventilatory weaning 10 days after cardiac surgery among patients still undergoing mechanical
ventilation on day 3. The simple scoring system based on this multivariable model might help to
predict successful weaning and hence avoid a needless tracheostomy.
954 Preoperative C-reactive protein levels to predict early and late mortalities after
coronary artery bypass surgery: Eight years of follow-up
Albert H. M. van Straten, MD, Mohamed A. Soliman Hamad, MD,
Andre´ J. van Zundert, MD, PhD, FRCA, Elisabeth J. Martens, PhD,
Jacques P. A. M. Scho¨nberger, MD, PhD, and Andre M. de Wolf, MD, PhD, Eindhoven and Tilburg,
The Netherlands; Ghent, Belgium; and Chicago, Ill
Patients who underwent coronary artery bypass grafting between January 2000 and December 2007
(n5 8500) were studied. Preoperative C-reactive protein level greater than 10mg/Lwas an independent
risk factor for early mortality; level greater than 5 mg/L was a risk factor for late mortality.
(continued on page 22A)
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S959 Prophylactic nesiritide does not prevent dialysis or all-cause mortality in
patients undergoing high-risk cardiac surgery
A. Ahsan Ejaz, MD, Tomas D. Martin, MD, Richard J. Johnson, MD, Almut G. Winterstein, PhD,
Charles T. Klodell, MD, Philip J. Hess, Jr, MD, Ayad K. Ali, PharmD, Elaine M. Whidden, ARNP,
Nancy L. Staples, RN, James A. Alexander, MD, Mary Ann House-Fancher, ARNP, and
Thomas M. Beaver, MD, MPH, Gainesville, Fla, and Denver, Colo
Prophylactic use of nesiritide did not decrease the incidence of dialysis and/or death in patients
undergoing high-risk cardiac surgery.
965 Preoperative anemia in patients undergoing coronary artery bypass grafting
predicts acute kidney injury
Luca De Santo, MD, Gianpaolo Romano, MD, Alessandro Della Corte, MD, PhD,
Vincenzo de Simone, MD, Francesco Grimaldi, MD, Maurizio Cotrufo, MD, and Marisa de Feo, PhD,
Foggia and Naples, Italy
Recent studies suggested that low preoperative hemoglobin concentration may affect cardiac
surgery outcomes. In this single-center prospective study on 1047 consecutive patients undergoing
CABG, anemia proved an independent predictor of AKI (OR, 2.06; 95% CI, 1.14–3.70), although
no dose–response relationship emerged between anemia severity and AKI.
971 Preoperative renal function as a predictor of survival after coronary artery
bypass grafting: Comparison with a matched general population
Albert H. M. van Straten, MD, Mohamed A. Soliman Hamad, MD, Andre´ A. J. van Zundert, MD,
PhD, FRCA, Elisabeth J. Martens, PhD, Jacques P. A. M. Scho¨nberger, MD, PhD, and
Andre M. de Wolf, MD, Eindhoven, The Netherlands, Ghent, Belgium, and Chicago, Ill
We retrospectively studied 10,359 patients who had isolated CABG between 1998 and 2007. Severity
of renal dysfunction was related to poor survival. When compared with expected survival, however,
our patients having coronary bypass had a worse outcome only when severe preoperative renal
dysfunction was present.
Evolving Technology/
Basic Science (ET/BS)
977 Hydrogen sulfide therapy attenuates the inflammatory response in a porcine
model of myocardial ischemia/reperfusion injury
Neel R. Sodha, MD, Richard T. Clements, PhD, Jun Feng, MD, PhD, Yuhong Liu, MD,
Cesario Bianchi, MD, PhD, Eszter M. Horvath, MD, Csaba Szabo, MD, PhD, Gregory L. Stahl, PhD,
and Frank W. Sellke, MD, Boston, Mass, Newark, NJ, and Seattle, Wash
This study examines the effects of therapeutic sulfide on myocardial I/R injury and inflammation in
a porcine model. Therapeutic sulfide is shown to attenuate I/R injury, limiting infarct size and release of
proinflammatory cytokines, as well as preserving myocardial and coronary microvascular function.
985 Layered implantation of myoblast sheets attenuates adverse cardiac remodeling
of the infarcted heart
Naosumi Sekiya, MD, Goro Matsumiya, MD, PhD, Shigeru Miyagawa, MD, PhD,
Atsuhiro Saito, PhD, Tatsuya Shimizu, MD, PhD, Teruo Okano, PhD, Naomasa Kawaguchi, PhD,
Nariaki Matsuura, MD, PhD, and Yoshiki Sawa, MD, PhD, Osaka and Tokyo, Japan
Implantation of layered myoblast sheets, up to five layers thick, onto infarcted rat hearts yielded
favorable results with improvement of cardiac function, induction of angiogenesis, more elastic
fibers, and less fibrosis. In optimal numbers, layered myoblast sheets may attenuate adverse cardiac
remodeling of the infarcted heart.
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22A The Journal of Thoracic and Cardiovascular Surgery c October 2009
Table of Contents (continued)
ED
IT
O
RI
A
L
G
TS
A
CD
CH
D
PM
ET
/B
S994 Association of electrostimulation with cell transplantation in ischemic heart disease
Abdel Shafy, MD, Thomas Lavergne, MD, Christian Latremouille, MD, PhD,
Miguel Cortes-Morichetti, MD, Alain Carpentier, MD, PhD, and Juan C. Chachques, MD, PhD,
Paris, France
Atrial synchronized biventricular pacing is indicated in patients with heart failure to correct
conduction disorders associated with chronic systolic and diastolic dysfunction. Electrostimulation
associated with cellular cardiomyoplasty was performed to transform passive cell therapy into
‘‘dynamic cellular support.’’ Thus, the principles of electrophysiologic conditioning of muscle fibers
(eg, dynamic cardiomyoplasty) were applied in an ischemic model treated with skeletal myoblasts.
Electrostimulation of both ventricles induced the contraction of the transplanted cells and a higher
expression of slow myosin, which is better adapted for chronic ventricular assistance.
1002 Cerebral tumor necrosis factor a expression and long-term neurocognitive
performance after cardiopulmonary bypass in rats
Bettina Jungwirth, MD, Kristine Kellermann, DVM, Ma Qing, MD, G. Burkhard Mackensen, MD,
Manfred Blobner, MD, and Eberhard F. Kochs, MD, Mu¨nchen, Germany, and Durham, NC
This study shows cerebral tumor necrosis factor a activation after cardiopulmonary bypass
(CPB), as well as after a sham operation, during the early postoperative period in rats
accompanied by a transient neurocognitive impairment. In this model, CPB alone showed no
effect on cerebral inflammation and neurocognitive outcome compared with that seen after the
sham operation.
1008 Bone morphogenic protein 2 induces Runx2 and osteopontin expression
in human aortic valve interstitial cells: Role of Smad1 and extracellular
signal-regulated kinase 1/2
Xiaoping Yang, PhD, Xianzhong Meng, MD, PhD, Xin Su, MD, David C. Mauchley, MD,
Lihua Ao, BS, Joseph C. Cleveland, Jr, MD, and David A. Fullerton, MD, Aurora, Colo
Bone morphogenic protein 2 (BMP-2) is a mediator of osteogenesis and is found in calcified areas of
stenotic aortic valves. In the present study, we found that stimulation of aortic valve interstitial cells
with BMP-2 led to the expression of the osteogenic factors Runx2 and osteopontin.
Brief Technique Reports 1016 First successful transapical aortic valve implantation after aortic allograft
replacement
Michael Schmoeckel, MD, Peter Boekstegers, MD, Konstantin Nikolaou, MD, and
Bruno Reichart, MD, Munich, Germany
1018 Minimally invasive transapical aortic valve-in-a-valve implantation for severe
aortic regurgitation in a degenerated stentless bioprosthesis
Timotheos G. Kelpis, MD, Nikolaos E. Mezilis, MD, FESC, Vlasis N. Ninios, MD, MRCP, and
Antonis A. Pitsis, MD, FETCS, FESC, Thessaloniki, Greece
1020 ‘‘Valve-in-valve’’ implantation in a patient with stentless bioprosthesis
and severe intraprosthetic aortic regurgitation
David Attias, MD, Dominique Himbert, MD, Ulrik Hvass, MD, and Alec Vahanian, MD, PhD,
Paris, France
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S1022 Feasibility of transapical aortic valve implantation fully guided by
transesophageal echocardiography
Eric Dumont, MD, Jeroˆme Lemieux, MD, Daniel Doyle, MD, and Josep Rode´s-Cabau, MD, FESC,
Que´bec, Canada
1025 Aortic valve replacement and mitral valve repair as treatment of complications
after percutaneous core valve implantation
Chiara Comoglio, MD, Massimo Boffini, MD, Suad El Qarra, MD, Fabrizio Sansone, MD,
Maurizio D’Amico, MD, Sebastiano Marra, MD, and Mauro Rinaldi, Professor, Turin, Italy
1027 Totally percutaneous valve replacement for severe aortic regurgitation in
a degenerating bioprosthesis
Massimo Napodano, MD, Ada Cutolo, MD, Chiara Fraccaro, MD, Giuseppe Tarantini, MD, PhD,
Raffaele Bonato, MD, Roberto Bianco, MD, Gino Gerosa, MD, Sabino Iliceto, and
Angelo Ramondo, MD, Padova, Italy
1029 Transcranial Doppler-guided selective antegrade cerebral perfusion during
aortic debranching operation
Ali Khoynezhad, MD, FACC, FACP, and Rolando Celis, MD, Omaha, Neb
1031 Delayed type A dissection after arch transposition and stent graft therapy of
a type B dissection
Curtis A. Anderson, MD, Evelio Rodriguez, MD, Michael C. Stoner, MD, and Alan P. Kypson, MD,
Greenville, NC
1032 Ascending aortic arch replacement with aortic valve resuspension under deep
hypothermic arrest combined with endoluminal stenting of the descending
thoracic aorta and the entire abdominal aorta
Maqsood M. Elahi, FACS, Mahmoud Jafari Giv, MBBS, Mayur Krishnaswamy, MBBS,
Craig McLachlan, PhD, Peter J. Mossop, FRACR, and Ian K. Nixon, FRACS,
Southampton, United Kingdom; and Melbourne and Sydney, Australia
1035 Endoprosthetic exclusion of type A aortic dissection through carotid artery
Patrick Ruchat, MD, Pierre-Guy Chassot, MD, and Elena Rizzo, MD, Lausanne, Switzerland
Letters to the Editor 1038 Acute hepatitis C virus and the cardiac surgeon: An explanation needed
Carlos-A. Mestres, MD, PhD, FETCS, Barcelona, Spain
1038 Reply to the Editor
R. Scott Thorston, MD, FACS, Baton Rouge, La
Meeting Proceedings 1039 Latest information for the thoracic surgeon from the Annual Meeting of the
American Society of Clinical Oncology
Sarita Dubey, MD, and Giorgio Scagliotti, MD, PhD, San Francisco, Calif; and
Orbassano (Torino), Italy
Meetings and Courses 1041 Meetings and Courses
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